Investor profile
Marianne Mertens
Venture capital & Partner at Apollo Health Ventures, Investment Committee Member at Alzheimer's Drug Discovery Foundation
Marianne Mertens works as an Investment Committee Member at Alzheimer's Drug Discovery Foundation. The firm's known portfolio counts 11 companies.
Is Marianne Mertens a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- Aging TherapeuticsBiotechDiagnosticsDrug DiscoveryGenomicsLongevityMedTechNeurosciencePharmaVenture Philanthropy
Contacts
Affiliated funds' portfolios
Partner at Apollo Health Ventures, whose known portfolio counts 9 companies
- Aeovian Pharmaceuticals
- Auron Therapeutics
- Haya Therapeutics
- Scripta Therapeutics
- Therini Bio
- Cognito Therapeutics
- Cleara Biotech
- Refoxy Pharma
- Booster Therapeutics
Investment Committee Member at Alzheimer's Drug Discovery Foundation, whose known portfolio counts 11 companies
- Astrocyte Pharmaceuticals
- ADmit Therapeutics
- APRINOIA Therapeutics
- CuraSen Therapeutics
- BrainScope Company
- Superfluid Dx
- ALZpath
- BrainScope
- GliaPharm
- Imeka
- NeuroAge Therapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Aging Therapeutics, Biotech, Diagnostics and Drug Discovery. Startups operating in these areas may find Marianne Mertens relevant.
Alzheimer's Drug Discovery Foundation appears in Growth, Seed and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Marianne Mertens matches their raise.
Colleagues
Gary Lauder
Member of Board of Governors
San Francisco, United States
Michael Kowalski
Mission-Related Investments Coordinator
Brooklyn, United States
Gabriel Kienberger
Partner Manager
Hamburg, Germany
Alexandra Sharon Bause
Investor
Munich, Germany
Jan Adams
Advisor & Managing Director
Berlin, Germany
Alan O'Connell
Scientific Advisory Board Member
Ireland
Ole Mensching
General Partner
France
Frequently asked questions
Who is Marianne Mertens?
Marianne Mertens is a venture capital investor based in Munich, Bavaria, Germany, listed as Investment Committee Member at Alzheimer's Drug Discovery Foundation. The known portfolio of that firm counts 11 companies. That portfolio belongs to the firm, not to Marianne Mertens personally.
What does Marianne Mertens invest in?
Listed sectors include Healthcare; listed focus areas include Aging Therapeutics, Biotech, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Marianne Mertens invest at?
Alzheimer's Drug Discovery Foundation appears in Growth, Seed and Series A rounds across its known deals, and Marianne Mertens is listed there as Investment Committee Member. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Marianne Mertens listed at?
Marianne Mertens is listed as Investment Committee Member at Alzheimer's Drug Discovery Foundation. 7 other people in the database share a firm with Marianne Mertens.
How do I contact Marianne Mertens?
An email address, a phone number and a LinkedIn page are on file for Marianne Mertens. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal